Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NCI R01 CA238039
National Institutes of Health
Grant: P01 CA163222
National Institutes of Health
Grant: R01 AR072304
National Institutes of Health
Grant: R01 CA222871
National Institutes of Health
Grant: R01 AR043369-19
NCI NIH HHS
Grant: R01 CA238039
NIAMS NIH HHS
Grant: R01 AR043369
National Institutes of Health
Grant: 5R01AR072304-04
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
National Institutes of Health
Grant: 5R01AR043369-28
MITF from control of pigmentation to melanoma risk
National Institutes of Health
Grant: 5R01CA238039-05
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
National Institutes of Health
Grant: 5P01CA163222-08
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
National Institutes of Health
Grant: 1R01CA222871-01
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Dana-Farber/Harvard Cancer Center
Massachusetts Institute of Technology
A*STAR
FWCI
2.68
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals